These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 11686010)

  • 1. Thymidylate synthase inhibitors.
    Ismail AS; Grem JL
    Cancer Chemother Biol Response Modif; 2001; 19():1-19. PubMed ID: 11686010
    [No Abstract]   [Full Text] [Related]  

  • 2. Thymidylate synthase inhibitors.
    Ackland SP; Clarke SJ; Beale P; Peters GJ
    Cancer Chemother Biol Response Modif; 2002; 20():1-36. PubMed ID: 12703198
    [No Abstract]   [Full Text] [Related]  

  • 3. Thymidylate synthase inhibitors as anticancer agents: from bench to bedside.
    Chu E; Callender MA; Farrell MP; Schmitz JC
    Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S80-9. PubMed ID: 12819937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymidylate synthase inhibitors in colorectal cancer.
    Cassidy J
    Semin Oncol; 2000 Oct; 27(5 Suppl 10):83-7. PubMed ID: 11049037
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of poly(ADP-ribose) polymerase in cancer.
    Plummer ER
    Curr Opin Pharmacol; 2006 Aug; 6(4):364-8. PubMed ID: 16753340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel targets for therapy in paediatric oncology.
    Estlin EJ
    Curr Drug Targets Immune Endocr Metabol Disord; 2002 Jul; 2(2):141-50. PubMed ID: 12476788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oxaliplatin: perspectives and future developments].
    Marty M; Cottu PH; Lerebours F; Bedairia N; Hocini H; Espié M
    Bull Cancer; 2001 Aug; 88 Spec No():S5-8. PubMed ID: 11567907
    [No Abstract]   [Full Text] [Related]  

  • 8. Promising new agents for treatment of patients with colorectal cancer.
    Von Hoff DD
    Semin Oncol; 1998 Oct; 25(5 Suppl 11):47-52. PubMed ID: 9786316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymidylate synthase inhibitors.
    Takimoto CH; Diggikar S
    Cancer Chemother Biol Response Modif; 2005; 22():1-18. PubMed ID: 16110605
    [No Abstract]   [Full Text] [Related]  

  • 10. Farnesyl transferase inhibitors.
    Li T; Sparano JA
    Cancer Invest; 2008 Aug; 26(7):653-61. PubMed ID: 18665473
    [No Abstract]   [Full Text] [Related]  

  • 11. Topoisomerase II inhibitors.
    Clapp JM; Hande KR
    Cancer Chemother Biol Response Modif; 2002; 20():125-49. PubMed ID: 12703203
    [No Abstract]   [Full Text] [Related]  

  • 12. Histone deacetylase inhibitors in cancer therapy.
    Fouladi M
    Cancer Invest; 2006; 24(5):521-7. PubMed ID: 16939962
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetics, safety, and efficacy of a liposome encapsulated thymidylate synthase inhibitor, OSI-7904L [(S)-2-[5-[(1,2-dihydro-3-methyl-1-oxobenzo[f]quinazolin-9-yl)methyl]amino-1-oxo-2-isoindolynl]-glutaric acid] in mice.
    Desjardins J; Emerson DL; Colagiovanni DB; Abbott E; Brown EN; Drolet DW
    J Pharmacol Exp Ther; 2004 Jun; 309(3):894-902. PubMed ID: 14982966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of the therapeutic efficacy of thymidylate synthase inhibitors.
    Peters GJ; Kuiper CM; van Triest B; Backus H; van der Wilt CL; van Laar JA; Jansen G; van Groeningen CJ; Pinedo HM
    Adv Exp Med Biol; 1998; 431():699-704. PubMed ID: 9598155
    [No Abstract]   [Full Text] [Related]  

  • 15. Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance.
    Taddia L; D'Arca D; Ferrari S; Marraccini C; Severi L; Ponterini G; Assaraf YG; Marverti G; Costi MP
    Drug Resist Updat; 2015 Nov; 23():20-54. PubMed ID: 26690339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence-based identification of specific drug target regions in the thymidylate synthase enzyme family.
    Ferrari S; Losasso V; Costi MP
    ChemMedChem; 2008 Mar; 3(3):392-401. PubMed ID: 18270995
    [No Abstract]   [Full Text] [Related]  

  • 17. Aurora kinases dawn as cancer drug targets.
    Sausville EA
    Nat Med; 2004 Mar; 10(3):234-5. PubMed ID: 14991042
    [No Abstract]   [Full Text] [Related]  

  • 18. Issues and progress with protein kinase inhibitors for cancer treatment.
    Dancey J; Sausville EA
    Nat Rev Drug Discov; 2003 Apr; 2(4):296-313. PubMed ID: 12669029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I study of OSI-7904L, a novel liposomal thymidylate synthase inhibitor in patients with refractory solid tumors.
    Beutel G; Glen H; Schöffski P; Chick J; Gill S; Cassidy J; Twelves C
    Clin Cancer Res; 2005 Aug; 11(15):5487-95. PubMed ID: 16061865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New targets for cancer chemotherapy.
    Murgo AJ; Dancey J; Eckhardt SG; Hidalgo M; Arbuck SG; Zerivitz K; Blaylock BA
    Cancer Chemother Biol Response Modif; 2002; 20():239-72. PubMed ID: 12703208
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.